[go: up one dir, main page]

ATE366577T1 - Behandlung der diabetes mit thiazolidindione und sulphonylurea - Google Patents

Behandlung der diabetes mit thiazolidindione und sulphonylurea

Info

Publication number
ATE366577T1
ATE366577T1 AT98935126T AT98935126T ATE366577T1 AT E366577 T1 ATE366577 T1 AT E366577T1 AT 98935126 T AT98935126 T AT 98935126T AT 98935126 T AT98935126 T AT 98935126T AT E366577 T1 ATE366577 T1 AT E366577T1
Authority
AT
Austria
Prior art keywords
thiazolidindione
sulphonylurea
diabetes
treatment
Prior art date
Application number
AT98935126T
Other languages
English (en)
Inventor
Robin Buckingham
Stephen Smith
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10816177&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE366577(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Application granted granted Critical
Publication of ATE366577T1 publication Critical patent/ATE366577T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT98935126T 1997-07-18 1998-07-16 Behandlung der diabetes mit thiazolidindione und sulphonylurea ATE366577T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9715306A GB9715306D0 (en) 1997-07-18 1997-07-18 Novel method of treatment

Publications (1)

Publication Number Publication Date
ATE366577T1 true ATE366577T1 (de) 2007-08-15

Family

ID=10816177

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98935126T ATE366577T1 (de) 1997-07-18 1998-07-16 Behandlung der diabetes mit thiazolidindione und sulphonylurea

Country Status (40)

Country Link
EP (1) EP0998291B2 (de)
JP (2) JP2001510158A (de)
KR (1) KR100680667B1 (de)
CN (1) CN1264302A (de)
AP (1) AP1318A (de)
AR (2) AR016768A1 (de)
AT (1) ATE366577T1 (de)
AU (1) AU743269B2 (de)
BG (1) BG64892B1 (de)
BR (1) BR9810904A (de)
CA (1) CA2297115C (de)
CO (1) CO4940422A1 (de)
CY (1) CY1107745T1 (de)
CZ (1) CZ302668B6 (de)
DE (1) DE69838066T3 (de)
DK (1) DK0998291T4 (de)
DZ (1) DZ2564A1 (de)
EA (1) EA003303B1 (de)
ES (1) ES2290989T5 (de)
GB (1) GB9715306D0 (de)
HU (1) HU229119B1 (de)
ID (1) ID24198A (de)
IL (1) IL134045A0 (de)
IN (1) IN189035B (de)
MA (1) MA26522A1 (de)
MY (1) MY138246A (de)
NO (1) NO326356B1 (de)
NZ (3) NZ515555A (de)
OA (1) OA11632A (de)
PE (1) PE99799A1 (de)
PL (2) PL199125B1 (de)
PT (1) PT998291E (de)
SI (1) SI0998291T2 (de)
SK (2) SK288053B6 (de)
TR (1) TR200000135T2 (de)
TW (1) TW586926B (de)
UA (1) UA70302C2 (de)
UY (1) UY25103A1 (de)
WO (1) WO1999003476A1 (de)
ZA (1) ZA986365B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7045519B2 (en) 1998-06-19 2006-05-16 Chiron Corporation Inhibitors of glycogen synthase kinase 3
EP1897547A1 (de) * 1999-07-13 2008-03-12 Medicure Inc. Verwendung der Pyridoxalphosphatderivate zur Behandlung von Diabetes und Komplikationen davon
EP1832291A3 (de) * 1999-07-13 2009-11-04 Medicure Inc. Verwendung der Pyridoxalphosphat zur Behandlung von Diabetes und Komplikationen davon
US6586438B2 (en) 1999-11-03 2003-07-01 Bristol-Myers Squibb Co. Antidiabetic formulation and method
US20010036479A1 (en) 2000-01-14 2001-11-01 Gillian Cave Glyburide composition
ATE508738T1 (de) 2001-01-12 2011-05-15 Sun Pharma Advanced Res Co Ltd System zur beabstandeten abgabe von arzneimitteln
KR100952090B1 (ko) 2003-10-31 2010-04-13 다케다 야쿠힌 고교 가부시키가이샤 인슐린 감작제, 인슐린 분비촉진제 및 폴리옥시에틸렌소르비탄 지방산 에스테르를 함유하는 고체 제제
JP2008019169A (ja) * 2004-10-25 2008-01-31 Osaka Univ 新規ｐｐａｒ調節剤およびそのスクリーニング方法
PE20110019A1 (es) 2005-12-22 2011-01-27 Takeda Pharmaceutical Composicion farmaceutica que contiene un sensibilizante de insulina y un secretagogo de insulina

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5522636A (en) * 1978-08-04 1980-02-18 Takeda Chem Ind Ltd Thiazoliding derivative
JPS5697277A (en) * 1980-01-07 1981-08-05 Takeda Chem Ind Ltd Thiazolidine derivative
JPS6051189A (ja) * 1983-08-30 1985-03-22 Sankyo Co Ltd チアゾリジン誘導体およびその製造法
US4582839A (en) * 1984-03-21 1986-04-15 Takeda Chemical Industries, Ltd. 2,4-thiazolidinediones
CN1003445B (zh) * 1984-10-03 1989-03-01 武田药品工业株式会社 噻唑烷二酮衍生物，其制备方法和用途
JPH06779B2 (ja) * 1985-06-10 1994-01-05 武田薬品工業株式会社 チアゾリジオン誘導体およびそれを含んでなる医薬組成物
US4812570A (en) * 1986-07-24 1989-03-14 Takeda Chemical Industries, Ltd. Method for producing thiazolidinedione derivatives
EP0306228B1 (de) * 1987-09-04 1999-11-17 Beecham Group Plc Substituierte Thiazolidindionderivate
US4791125A (en) * 1987-12-02 1988-12-13 Pfizer Inc. Thiazolidinediones as hypoglycemic and anti-atherosclerosis agents
WO1989008650A1 (en) * 1988-03-08 1989-09-21 Pfizer Inc. Thiazolidinedione hypoglycemic agents
WO1989008651A1 (en) * 1988-03-08 1989-09-21 Pfizer Inc. Hypoglycemic thiazolidinedione derivatives
WO1991007107A1 (en) * 1989-11-13 1991-05-30 Pfizer Inc. Oxazolidinedione hypoglycemic agents
JPH04210683A (ja) * 1990-12-06 1992-07-31 Terumo Corp チアゾリジン−２，４−ジオン誘導体およびこれを含有する糖尿病合併症治療薬
US5183823A (en) * 1991-04-11 1993-02-02 Takeda Chemical Industries, Ltd. Pyridine n-oxide compounds which are useful as hypoglycemic and hypolipidemic agents
ATE139130T1 (de) * 1991-08-16 1996-06-15 Sandoz Ag Inhalator zur verabreichung von pulverförmigen substanzen
EP0601001B1 (de) * 1991-08-26 1997-04-16 PHARMACIA & UPJOHN COMPANY Flüssiges nahrungsmittel, das 3-guanidinopropionsäure enthält
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
TW438587B (en) * 1995-06-20 2001-06-07 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes
US5859037A (en) * 1997-02-19 1999-01-12 Warner-Lambert Company Sulfonylurea-glitazone combinations for diabetes

Also Published As

Publication number Publication date
BR9810904A (pt) 2000-09-26
SK287823B6 (sk) 2011-11-04
TR200000135T2 (tr) 2000-05-22
AR019331A2 (es) 2002-02-13
UY25103A1 (es) 2000-12-29
ES2290989T3 (es) 2008-02-16
ID24198A (id) 2000-07-13
WO1999003476A1 (en) 1999-01-28
DE69838066T2 (de) 2008-03-20
EA003303B1 (ru) 2003-04-24
PL338127A1 (en) 2000-09-25
BG64892B1 (bg) 2006-08-31
DK0998291T3 (da) 2007-11-05
CA2297115A1 (en) 1999-01-28
DE69838066D1 (de) 2007-08-23
AU743269B2 (en) 2002-01-24
EP0998291B2 (de) 2011-07-06
EP0998291B1 (de) 2007-07-11
EP0998291A1 (de) 2000-05-10
IL134045A0 (en) 2001-04-30
BG104139A (en) 2000-11-30
NZ520652A (en) 2004-06-25
AP1318A (en) 2004-10-22
AU8448798A (en) 1999-02-10
IN189035B (de) 2002-12-07
NO20000229D0 (no) 2000-01-17
PL199125B1 (pl) 2008-08-29
CN1264302A (zh) 2000-08-23
CA2297115C (en) 2010-02-23
CZ2000173A3 (en) 2001-05-16
MY138246A (en) 2009-05-29
AP2000001734A0 (en) 2000-03-31
KR20010021948A (ko) 2001-03-15
ES2290989T5 (es) 2011-11-11
NZ515555A (en) 2002-09-27
DK0998291T4 (da) 2011-09-26
MA26522A1 (fr) 2004-12-20
GB9715306D0 (en) 1997-09-24
DE69838066T3 (de) 2012-03-29
ZA986365B (en) 2000-01-17
PT998291E (pt) 2007-10-11
SI0998291T2 (sl) 2011-10-28
HU229119B1 (en) 2013-08-28
HUP0003634A3 (en) 2003-04-28
SK288053B6 (sk) 2013-03-01
NO20000229L (no) 2000-01-17
DZ2564A1 (fr) 2003-02-15
EA200000141A1 (ru) 2000-08-28
SI0998291T1 (sl) 2007-12-31
CZ302668B6 (cs) 2011-08-24
AR016768A1 (es) 2001-08-01
OA11632A (en) 2004-11-22
PE99799A1 (es) 1999-12-22
CO4940422A1 (es) 2000-07-24
TW586926B (en) 2004-05-11
KR100680667B1 (ko) 2007-02-09
CY1107745T1 (el) 2013-04-18
SK602000A3 (en) 2000-07-11
JP2005247865A (ja) 2005-09-15
UA70302C2 (uk) 2004-10-15
NO326356B1 (no) 2008-11-17
HK1029272A1 (en) 2001-03-30
HUP0003634A2 (hu) 2001-07-30
JP2001510158A (ja) 2001-07-31
NZ501256A (en) 2002-09-27

Similar Documents

Publication Publication Date Title
ATE355840T1 (de) Behandlung der diabetes mit thiazolidindione und metformin
DE69817446D1 (de) Behandlung von diabetes
FI970357L (fi) Tyypin II diabeteksen hoitoon käyttökelpoisia bensoksatsoli- ja pyridiinijohdannaisia
EE9900345A (et) Sulfonüülkarbamiidi ja glitasooni sünergistilised kombinatsioonid diabeedi raviks
FI964314A7 (fi) Substituoidut sulfonamidit selektiivisinä beta3-agonisteina diabeteksen ja liikalihavuuden hoitoon
DE69836008D1 (de) Zusammensetzung und behandlungsmittel
DE69835011D1 (de) Unterschiedliche behandlung von prothesenteilen
DE69831755D1 (de) Optoakustische kontrastmittel und anwendungsverfahren
ATE292975T1 (de) Verwendung von tetrahydolipstatin in der behandlung von diabetes typ ii
EP0996433A4 (de) Behandlungsverfahren von lactosylceramidbedingten zuständen
FI965204A0 (fi) Bromelaiinin lääkekäyttö
ATE353654T1 (de) Behandlung der diabetes mit thiazolidindione und sulphonylurea
DE69838066D1 (de) Behandlung der diabetes mit thiazolidindione und sulphonylurea
PL337577A1 (en) Treatment of diabetes with thiazolydinone and alpha - glucosidaze inhibitor
DE69705328D1 (de) Organischer photogeleiter und dessen behandlung
FI963263A0 (fi) Bromelaiinin lääkinnällinen käyttö
FI974609L (fi) Uusia heterosyklisiä yhdisteitä kivun hoitoon ja niiden käyttö
DE69713442D1 (de) Thioürazil-Derivate und diese enthaltende Metall-Oberflächebehandlungsmittel
ID24439A (id) Penggunaan tiazolidindion untuk pengobatan hiperglikemia
ATE432709T1 (de) Behandlung von diabetes
ID24521A (id) Penggunaan tiazolidindion untuk pengobatan hiperglikemia
ID17459A (id) Unsur-unsur pengobatan
UA25095A (uk) Ліhімеhт для лікуваhhя каhдидозhого і змішаhого вульвовагіhіту
NO995940D0 (no) Anvendelse av leptin antagonister for behandling av diabetes
LV12070A (lv) Ierice rokas zaga zobu asinasanai

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0998291

Country of ref document: EP